GenomesDAO GENOME is projected to decline to $0.0001945 by 2027, a -43% move from its current price of $0.0003398. GENOME is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell. Market sentiment sits at 23/100 (Extreme Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via CoinGecko & CoinMarketCap · updated 7/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 6 | $0.0003262 | $0.0003395 | $0.0003534 | -0.08% |
| Jul 7 | $0.0003206 | $0.0003393 | $0.000359 | -0.16% |
| Jul 8 | $0.0003163 | $0.000339 | $0.0003633 | -0.24% |
| Jul 9 | $0.0003127 | $0.0003387 | $0.0003669 | -0.32% |
| Jul 10 | $0.0003095 | $0.0003384 | $0.0003701 | -0.41% |
| Jul 11 | $0.0003066 | $0.0003382 | $0.000373 | -0.49% |
| Jul 12 | $0.000304 | $0.0003379 | $0.0003756 | -0.57% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.000304 | $0.0003379 | $0.0003756 | -0.57% |
| Week 2 | $0.0002893 | $0.000336 | $0.0003902 | -1.13% |
| Week 3 | $0.0002781 | $0.0003341 | $0.0004013 | -1.69% |
| Week 4 | $0.0002688 | $0.0003322 | $0.0004105 | -2.25% |
| Week 5 | $0.0002607 | $0.0003303 | $0.0004184 | -2.81% |
| Week 6 | $0.0002534 | $0.0003284 | $0.0004256 | -3.36% |
| Week 7 | $0.0002468 | $0.0003265 | $0.000432 | -3.91% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
GENOME is the new token from GenomesDAO - Replacing $GENE and $GNOME to create one new super utility token for the Genomes platform.
GENOME sits within the Ethereum Ecosystem, Base Ecosystem, and Decentralized Science (DeSci).
As described, GENOME is positioned as a single, broad utility token for the Genomes platform.
GENOME trades at $0.0003398 and has a market cap of $339.82K. It ranks 3952 by market capitalization.
The near-term outlook reflects a bearish technical backdrop, with RSI and moving averages suggesting limited upside in the immediate horizon. Key levels to watch are support at $0.0003179 and resistance at $0.0004053.
The current price context sits near a shallow trough relative to its all-time high of $0.0586 and above its all-time low of $0.0002974, underscoring tight price action in a low-price tier.
A major floor 21.1% below — a decisive break under it would weaken the trend.
The nearest floor, 6.4% below — buyers have tended to step in here.
The nearest ceiling, 19.3% above — a clean break opens room to run.
A major ceiling 67.6% above — clearing it would confirm fresh momentum.
Key GENOME support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of GENOME market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.0003402 | Sell | $0.0003428 | Sell |
| MA 10 | $0.0003492 | Sell | $0.0003463 | Sell |
| MA 20 | $0.0003557 | Sell | $0.0003536 | Sell |
| MA 50 | $0.0003614 | Sell | $0.0003797 | Sell |
| MA 100 | $0.0004306 | Sell | $0.0004694 | Sell |
| MA 200 | $0.0006065 | Sell | $0.0008966 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 43.88 | Neutral |
| Stoch RSI (14) | 46.01 | Neutral |
| CCI (20) | -60.09 | Neutral |
| Williams %R (14) | -76.31 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | 2.89 | Buy |
| Bollinger %B (20,2) | 0.31 | Neutral |
| Stochastic %K (14) | 23.69 | Neutral |
| TRIX (15) | -0.34 | Sell |
| Awesome (5,34) | -0.00 | Sell |
| Ultimate (7,14,28) | 37.86 | Neutral |
| Momentum (10) | -0.00 | Sell |
| Aroon Osc (25) | 12.00 | Buy |
| Hull MA (9) | 0.00 | Buy |
| ADX (14) | 12.51 | Neutral |
| ATR (14) | 0.00 | Info |
The 30-day picture shows a range from $0.000273 to $0.000423, highlighting a tight, low-price band.
RSI14 is 40, indicating room for momentum to shift; the 50-day and 200-day moving levels sit at $0.0003614 and $0.0006065 respectively.
Support sits at $0.0003179 and resistance at $0.0004053, framing a cautious near-term path for GENOME.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.0003117 | $0.0003398 | $0.0003937 | 0% | Neutral | |
| $0.0001479 | $0.0001945 | $0.0002743 | -43% | Bearish | |
| $0.0003465 | $0.0004757 | $0.0007056 | +40% | Bullish | |
| $0.0002997 | $0.0004265 | $0.0006579 | +26% | Bullish | |
| $0.0001007 | $0.000148 | $0.0002359 | -56% | Bearish | |
| $0.0002846 | $0.000431 | $0.0007066 | +27% | Bullish | |
| $0.0003816 | $0.0005944 | $0.0009994 | +75% | Bullish | |
| $0.0001551 | $0.0002482 | $0.0004268 | -27% | Bearish | |
| $0.0001825 | $0.0002996 | $0.000526 | -12% | Neutral | |
| $0.0003878 | $0.0006525 | $0.001168 | +92% | Bullish | |
| $0.0003168 | $0.0005984 | $0.00116 | +76% | Bullish | |
| $0.0005379 | $0.001195 | $0.002596 | +252% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.0003117 | $0.0003398 | $0.0004313 | +0.00% |
| August 2026 | $0.0003078 | $0.0003694 | $0.0004596 | +8.71% |
| September 2026 | $0.0002604 | $0.0003155 | $0.0003984 | -14.59% |
| October 2026 | $0.0002252 | $0.0002753 | $0.000352 | -12.75% |
| November 2026 | $0.000246 | $0.0003029 | $0.0003913 | +10.01% |
| December 2026 | $0.0002434 | $0.0003017 | $0.0003937 | -0.37% |
Click any year to see its month-by-month GENOME forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, GENOME could reach as high as $0.0003937, with a base case around $0.0003398 and support toward $0.0003117 — roughly 0% from $0.0003398. Price action looks broadly range-bound.
Expect GENOME to range from $0.0001479 to $0.0002743 through 2027. The $0.0001945 average target implies a -43% move from current prices. That is -43% versus the projected 2026 average. Expect choppier, lower action through this leg of the cycle.
The GENOME price prediction for 2028 points to an average of $0.0004757 (low $0.0003465, high $0.0007056) — a potential gain of +40% on today's $0.0003398. Momentum favours further upside here.
In 2029, GENOME is projected to trade between $0.0002997 and $0.0006579, averaging $0.0004265 — a potential gain of +26% from today's $0.0003398. That is -10% versus the projected 2028 average. Buyers look set to stay in control over this stretch.
GenomesDAO GENOME's 2030 outlook centres on $0.000148, within a $0.0001007 to $0.0002359 range. That is -65% versus the projected 2029 average. That marks a -56% change versus current levels. A cyclical pullback looks likely — prices rarely move in a straight line.
By 2031, GENOME could reach as high as $0.0007066, with a base case around $0.000431 and support toward $0.0002846 — roughly +27% from $0.0003398. Buyers look set to stay in control over this stretch.
Expect GENOME to range from $0.0003816 to $0.0009994 through 2032. The $0.0005944 average target implies a +75% move from current prices. That is up +38% on the projected 2031 average. Momentum favours further upside here.
The GENOME price prediction for 2033 points to an average of $0.0002482 (low $0.0001551, high $0.0004268) — a potential decline of -27% on today's $0.0003398. Expect choppier, lower action through this leg of the cycle.
In 2034, GENOME is projected to trade between $0.0001825 and $0.000526, averaging $0.0002996 — a potential decline of -12% from today's $0.0003398. That is up +21% on the projected 2033 average. Price action looks broadly range-bound.
GenomesDAO GENOME's 2035 outlook centres on $0.0006525, within a $0.0003878 to $0.001168 range. That is up +118% on the projected 2034 average. That marks a +92% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, GENOME could reach as high as $0.00116, with a base case around $0.0005984 and support toward $0.0003168 — roughly +76% from $0.0003398. Momentum favours further upside here.
Expect GENOME to range from $0.0005379 to $0.002596 through 2050. The $0.001195 average target implies a +252% move from current prices. That is up +100% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in GENOME today (≈ 2,942,734.388794 GENOME) could be worth
$3,517.76
+$2,517.76 (+252%) by 2050 · US Dollar
Based on the average projected GENOME price of $0 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in GENOMEwould be worth at today's price.
$1,000 invested in GENOME on Jul 1, 2025 (≈ 249,315.826427 GENOME) would be worth
$84.72
-$915.28 (-91.5%) today · 0.08× · US Dollar
Based on a GENOME entry price of $0.004011 vs. today's $0.00034.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.00036 | $943.81 | -5.6% |
| 1 month ago | $0.000391 | $868.23 | -13.2% |
| 3 months ago | $0.000519 | $655.12 | -34.5% |
| 6 months ago | $0.000918 | $370.23 | -63.0% |
| 1 year ago | $0.004011 | $84.72 | -91.5% |
| All time (1.1y) ago | $0.006407 | $53.04 | -94.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our GENOME forecast.
Our base-case forecast reaches $0.00068 around 2050.
Implied market cap at $0.00068: $680K
The year-by-year forecast shows a mixed path, starting with 2026 where the avg is $0.0003398 and ROI is 0, with sentiment NEUTRAL.
The 2027 forecast enters a bearish phase (avg $0.0001945; ROI -42.8; sentiment BEARISH), followed by a bullish uptick in 2028 (avg $0.0004757; ROI 40; sentiment BULLISH) and 2029 (avg $0.0004265; ROI 25.5; sentiment BULLISH).
In 2030 the outlook turns bearish again (avg $0.000148; ROI -56.5; min $0.0001007; max $0.0002359; sentiment BEARISH), with gradual recovery into 2031 (avg $0.000431; ROI 26.8; sentiment BULLISH) and 2032 (avg $0.0005944; ROI 74.9; sentiment BULLISH).
The forecast also shows a continued cycle of volatility, with 2033 (avg $0.0002482; ROI -27; sentiment BEARISH) and 2034 (avg $0.0002996; ROI -11.8; sentiment NEUTRAL) before a strong upside in 2035 (avg $0.0006525; ROI 92; sentiment BULLISH). The longer horizon includes 2040 (avg $0.0005984; ROI 76.1; sentiment BULLISH) and a notable long-run peak in 2050 (avg $0.001195; ROI 251.8; max $0.002596; sentiment BULLISH; min $0.0005379).
These numbers illustrate a wide range of potential outcomes, with meaningful upside possible by mid-to-late decade and a significant long-horizon rise suggested by 2050. They are estimates, not guarantees, and reflect substantial volatility across the forecast.
Tap a question to reveal the answer.
2030 avg $0.000148; ROI -56.5; sentiment BEARISH. Min $0.0001007; Max $0.0002359.
Forecasts show a mix of gains and declines across years. Notable bullish years include 2028 (avg $0.0004757, ROI 40) and 2050 (avg $0.001195, ROI 251.8); bearish years include 2027 (avg $0.0001945, ROI -42.8) and 2030 (avg $0.000148, ROI -56.5). These are estimates, not guarantees.
The forecast points to a long-horizon target around $0.001, with 2050 avg $0.001195 and max $0.002596; 2040 also shows a path toward higher levels. Min values in the forecast (e.g., 2030 min $0.0001007, 2034 min $0.0001825) illustrate downside risk.
Current price $0.0003398; market cap $339.82K; rank 3952.
RSI14 40; SMA50 $0.0003614; SMA200 $0.0006065. The 30-day range is $0.000273 to $0.000423, with support at $0.0003179 and resistance at $0.0004053; sentiment is BEARISH.
GenomesDAO GENOME Community Discussion
0Share your GenomesDAO GENOME price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.